Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(TSX: SVA )

0.2800 +0.0100 (+3.70%)
Streaming Delayed Price Updated: 3:55 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 81,601
Open 0.2600
Bid (Size) 0.2750 (10)
Ask (Size) 0.2800 (20)
Prev. Close 0.2700
Today's Range 0.2600 - 0.2800
52wk Range 0.2600 - 0.9400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Provides Positive Clinical and Platform Portfolio Update
With recent positive findings in post-surgical hypothyroidism large animal study, Sernova anticipates filing an Investigational New Drug (IND) application in 2024 
Via TheNewswire.com

Performance

YTD
-61.11%
-61.11%
1 Month
-15.15%
-15.15%
3 Month
-34.88%
-34.88%
6 Month
-55.56%
-55.56%
1 Year
-69.57%
-69.57%

More News

Read More
Sinovac Amends Shareholder Rights Plan
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Announces Change of Legal Representative of Sinovac Beijing
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited First Half of 2023 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
Via Investor Brand Network
Sinovac Amends Shareholder Rights Plan
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited First Half of 2022 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
Via Benzinga
SINOVAC Varicella Vaccine Prequalified by WHO
From Sinovac Biotech Ltd.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
SINOVAC to Showcase Products at CPHI Frankfurt
From Sinovac Biotech Ltd.
Via Business Wire
SVA DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
SINOVAC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sinovac Biotech Ltd. (SVA) Investors of Class Action Deadline Against 1Globe Capital LLC and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Deadline in Lawsuit on October 17, 2022
Via SBWire
SVA FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA
From The Rosen Law Firm, P.A.
Via Business Wire
SVA FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.